Web of Science: 6 cites, Scopus: 7 cites, Google Scholar: cites,
The use of imaging techniques in chronic kidney disease-mineral and bone disorders (CKD-MBD)-A systematic review
Pimentel, A. (Department of Dialysis AURA Nord Saint Ouen)
Bover, Jordi (Institut d'Investigació Biomèdica Sant Pau)
Elder, G. (Department of Renal Medicine. Westmead Hospital)
Cohen-Solal, M. (Université de Paris. Hôpital Lariboisière)
Ureña-Torres, Pablo (University of Paris Descartes)

Data: 2021
Resum: Although frequently silent, mineral and bone disease (MBD) is one of the most precocious complication of chronic kidney disease (CKD) and is omnipresent in patients with CKD stage 5. Its pathophysiology is complex, but basically, disturbances in vitamin D, phosphate, and calcium metabolism lead to a diverse range of clinical manifestations with secondary hyperparathyroidism usually being the most frequent. With the decline in renal function, CKD-MBD may induce mi-crostructural changes in bone, vascular system and soft tissues, which results in macrostructural lesions, such as low bone mineral density (BMD) resulting in skeletal fractures, vascular and soft tissue calcifications. Moreover, low BMD, fractures, and vascular calcifications are linked with increased risk of cardiovascular mortality and all-cause mortality. Therefore, a better characterization of CKD-MBD patterns, beyond biochemical markers, is helpful to adapt therapies and monitor strategies as used in the general population. An in-depth characterization of bone health is required, which includes an evaluation of cortical and trabecular bone structure and density and the degree of bone remodeling through bone biomarkers. Standard radiological imaging is generally used for the diagnosis of fracture or pseudo-fractures, vascular calcifications and other features of CKD-MBD. However, bone fractures can also be diagnosed using computed tomography (CT) scan, magnetic resonance (MR) imaging and vertebral fracture assessment (VFA). Fracture risk can be predicted by bone densitometry using dual-energy X-ray absorptiometry (DXA), quantitative computed tomog-raphy (QTC) and peripheral quantitative computed tomography (pQTC), quantitative ultrasound (QUS) and most recently magnetic resonance micro-imaging. Quantitative methods to assess bone consistency and strength complete the study and adjust the clinical management when integrated with clinical factors. The aim of this review is to provide a brief and comprehensive update of imaging techniques available for the diagnosis, prevention, treatment and monitoring of CKD-MBD.
Drets: Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original. Creative Commons
Llengua: Anglès
Document: Article de revisió ; recerca ; Versió publicada
Matèria: Bone ; Fracture ; Bone mineral density ; Computed tomography ; Cortical bone ; Trabecular bone ; CKD-MBD ; Dual-energy X-ray absorptiometry
Publicat a: Diagnostics, Vol. 11 Núm. 5 (2021) , p. 772, ISSN 2075-4418

DOI: 10.3390/diagnostics11050772
PMID: 33925796


17 p, 3.2 MB

El registre apareix a les col·leccions:
Documents de recerca > Documents dels grups de recerca de la UAB > Centres i grups de recerca (producció científica) > Ciències de la salut i biociències > Institut de Recerca Sant Pau
Articles > Articles de recerca
Articles > Articles publicats

 Registre creat el 2023-02-16, darrera modificació el 2024-02-19



   Favorit i Compartir